TABLE 2.
Summary of the cases with ABPA successfully treated with dupilumab.
| Age | Sex | Comorbid disease | Treatment of ABPA | Previous treatment using biologics | References |
|---|---|---|---|---|---|
| 81 | F | Asthma | OCS (prednisolone) | Mepolizumab | 16 |
| 63 | F | Asthma | Itraconazole | Benralizumab | 17 |
| 45 | M | Asthma | OCS (prednisolone) | Mepolizumab | 18 |
| 49 | F | Asthma | Itraconazole, OCS (prednisolone) | Benralizumab, omalizumab | 19 |
| 60 | F | Asthma | OCS (unknown) | Omalizumab, mepolizumab | 20 |
| 51 | F | Asthma | Itraconazole, OCS (unknown) | Mepolizumab | 20 |
| 33 | M | Asthma, Klinefelter syndrome | Voriconazole | – | 20 |
| 72 | F | Asthma, NTM‐PD | – | – | 21 |
| 54 | F | Asthma | itraconazole, OCS(prednisolone) | – | 4 |
| 68 | F | Asthma | – | ‐ | Present case |
Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; NTM‐PD, non‐tuberculous mycobacterial‐pulmonary disease; OCS, oral corticosteroid.